Nuvectra Corp (NVTR)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
CEO:
Scott F. Drees
Employees:
197
5830 GRANITE PKWY, SUITE 1100, PLANO, TX 75024
972-668-4107

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Nuvectra Corp. engages in the development and commercialization of neurostimulation technology platform for treatment of various disorders through stimulation of tissues associated with the nervous systems. It also supports neurological indications such as sacral nerve stimulation, and deep brain stimulation. The company's technology, Algovita Spinal Cord Stimulation System, treats chronic pain of the trunk and limbs. Nuvectra was founded on November 14, 2008 and is headquartered in Plano, TX.

Data derived from most recent annual or quarterly report
Market Cap 2.326 Million Shares Outstanding17.89 Million Avg 30-day Volume 2.425 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-1.45
Price to Revenue0.0 Debt to Equity0.6423 EBITDA-43.828 Million
Price to Book Value0.0 Operating Margin-91.6026 Enterprise Value0
Current Ratio4.86 EPS Growth0.146 Quick Ratio4.284
1 Yr BETA 1.6956 52-week High/Low 0.0 / Profit Margin-101.7204
Operating Cash Flow Growth-22.0292 Altman Z-Score0.0 Free Cash Flow to Firm -30.486 Million

View recent insider trading info

Nuvectra Corp YCharts
Yahoo! Finance finviz

Funds Holding NVTR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NVTR

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HAWARI KENNETH G

  • Director
 29,955 2019-12-21 0

JOHNSON DAVID D

  • Director
 62,955 2019-12-21 0

BIHL ANTHONY P III

  • Director
 30,394 2019-12-21 0

KOSHAREK JENNIFER CFO

  • Officer
 77 2019-12-13 0

TRANCHINA BENJAMIN CHIEF TECHNOLOGY OFFICER

  • Officer
 30,793 2019-12-05 0

CHAVEZ CHRISTOPHER G.

  • Director
 1,937 2019-09-21 0

SONG JANE

  • Director
 1,937 2019-09-21 0

ZELIBOR THOMAS EDWARD

  • Director
 12,987 2019-09-21 0

TREMMEL JON T

  • Director
 23,205 2019-09-21 0

HANCHIN JOSEPH PAUL PRESIDENT

  • Officer
 45,377 2019-06-05 0

BERGER WALTER Z CFO

  • Officer
 107,135 2019-05-12 0

PARKS FRED B CEO

  • Officer
  • Director
 10,050 2019-04-09 0

MILLER JOSEPH A

  • Director
 60,106 2019-02-07 0

DREES SCOTT F CEO

  • Officer
  • Director
 221,344 2019-01-07 0

KAULA NORBERT EVP, RESEARCH & DEVELOPMENT

  • Officer
 15,467 2018-08-12 0

HICKMAN THOMAS KELLEY EVP, SALES & MARKETING

  • Officer
 No longer subject to file 2017-07-25 0

FAHEY KATHY JO VP OF REGULATORY & CLINICAL

  • Officer
 2,854 2017-04-07 0

GREATBATCH, INC.

  • 10% Owner
 No longer subject to file 2016-03-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments